We then compared all expanded TRB-CDR3 sequences identified from our targeted scRNAseq as well as our high-throughput whole transcriptome scRNAseq analyses against this RCC tumor-derived TCR repertoire database. Here, TRBV20OR9-2 is linked to neoplasm.